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Abstract
Background: Friedreich ataxia (FRDA), the most common autosomal recessive ataxia disorder, is caused by a dynamic GAA
repeat expansion mutation within intron 1 of FXN gene, resulting in down-regulation of frataxin expression. Studies of cell
and mouse models have revealed a role for the mismatch repair (MMR) MutS-heterodimer complexes and the PMS2
component of the MutLa complex in the dynamics of intergenerational and somatic GAA repeat expansions: MSH2, MSH3
and MSH6 promote GAA repeat expansions, while PMS2 inhibits GAA repeat expansions.
Methodology/Principal Findings: To determine the potential role of the other component of the MutLa complex, MLH1, in
GAA repeat instability in FRDA, we have analyzed intergenerational and somatic GAA repeat expansions from FXN
transgenic mice that have been crossed with Mlh1 deficient mice. We find that loss of Mlh1 activity reduces both
intergenerational and somatic GAA repeat expansions. However, we also find that loss of either Mlh1 or Pms2 reduces FXN
transcription, suggesting different mechanisms of action for Mlh1 and Pms2 on GAA repeat expansion dynamics and
regulation of FXN transcription.
Conclusions/Significance: Both MutLa components, PMS2 and MLH1, have now been shown to modify the molecular
phenotype of FRDA. We propose that upregulation of MLH1 or PMS2 could be potential FRDA therapeutic approaches to
increase FXN transcription.
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Introduction
Friedreich ataxia (FRDA) is a fatal, autosomal recessive
neurodegenerative disorder caused by homozygous GAA repeat
expansion within intron 1 of the FXN gene [1]. This mutation
induces heterochromatin formation [2], likely due to abnormal
non-B DNA or DNANRNA hybrid triplex structures [3,4], leading
to FXN gene silencing and thus reduced expression of the essential
mitochondrial protein, frataxin [5]. Frataxin insufficiency culmi-
nates in mitochondrial iron accumulation and reduced activity of
iron-sulfur (Fe-S) cluster enzymes, including mitochondrial respi-
ratory chain complexes and aconitase [6], leading to increased
susceptibility to oxidative stress and resultant cell degeneration.
The primary sites of FRDA pathology are the large sensory
neurons of the dorsal root ganglia (DRG) and the dentate nucleus
of the cerebellum [7]. However, there are also non-neuronal tissue
dysfunctions including diabetes and cardiomyopathy, followed by
death commonly in early adulthood [8,9]. Thus far, there is no
effective therapy for FRDA. Unaffected individuals carry FXN
alleles containing 5–32 GAA repeats, while this is expanded to
approximately 70–1700 GAA repeats in affected individuals, most
commonly between 600–900 repeats. The GAA repeats are
dynamic in FRDA patients, presenting both somatic and
intergenerational GAA repeat instability [10,11]. Somatic GAA
repeat expansion takes place progressively in many different tissues
throughout life, particularly in the DRG and cerebellum [12,13].
In addition, different modes of intergenerational repeat instability
have been detected. Thus, during maternal transmissions of GAA
repeat expansions, further expansions and contractions are equally
detected, while a bias towards contraction is observed during
paternal transmissions [14–17]. These findings indicate that GAA
repeat expansion dynamics might perform a critical role in FRDA
disease progression, and hence finding approaches to prevent
GAA repeat expansions or induce repeat contractions could be an
effective strategy to treat this disorder. To study FXN GAA repeat
instability and pathogenesis in FRDA, we have previously
established two lines of human FRDA YAC transgenic mice,
YG8 and YG22, containing GAA repeat expansion mutations
within the FXN transgene [18]. When crossed onto a mouse Fxn-
null genotype, these transgenic mice act as suitable models to study
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the molecular mechanisms of FXN dysfunction and to investigate
FRDA therapeutic strategies [19–24]. For instance, investigation
of YG8 and YG22 transgenic mice has revealed the age
dependence and tissue selectivity of somatic GAA repeat
expansions, particularly in cerebellum and DRG tissues [18,25].
Previous investigations of mouse models have indicated the role
of some mismatch repair (MMR) proteins in the CAG and CTG
repeat instability dynamics of the other trinucleotide repeat (TNR)
disorders, such as Huntington disease (HD) and myotonic
dystrophy type 1 (DM1) respectively [26]. By analyzing intergen-
erational transmissions of YG8 and YG22 mouse models, we have
similarly demonstrated that deficit of any of the Msh2, Msh3,
Msh6 or Pms2 parental MMR proteins increases GAA repeat
mutability (expansion and/or contraction) in the offspring.
Subsequently, we have shown that loss of MMR-MutSa hetero-
dimer protein components, Msh2 or Msh6, leads to a significant
decline in somatic GAA repeat expansions. In contrast, loss of
Pms2 protein increases GAA repeat expansions in neuronal
tissues, particularly the cerebellum and DRG. However, this effect
is not detectable in non-neuronal tissues, which are less susceptible
to FXN GAA repeat instability [27].
Mechanistically, MutS-heterodimers are recruited to recognize
base-base mismatches or small nucleotide insertion/deletion loops
(IDLs) during MMR function. This procedure is then continued
within eukaryotes by another MMR heterodimer complex, named
MutL. This heterodimer complex comprises 4 different homo-
logues: MLH1, MLH3, PMS1 and PMS2. MLH1 plays a central
role by interacting with PMS2, PMS1 or MLH3 to form the three
heterodimeric complexes MutLa, MutLb and MutLc, respective-
ly. MutLa-heterodimers can interact with both MutSa and
MutSb, but MutLc is only able to interact with MutSb during
the MMR process. The precise function of MutLb is not yet
determined [28,29]. Although several studies have revealed a
crucial role for MSH2, MSH3, MSH6 and PMS2 proteins on the
dynamics of trinucleotide repeat based diseases, there are limited
investigations of the MLH1 protein. However, recent studies of
Huntington disease HdhQ111 transgenic mice have shown that
Mlh1 is required to increase the CAG repeat expansion in somatic
tissues [30]. To study the potential role of Mlh1 protein on
intergenerational and somatic GAA repeat instability, we have
crossed YG22 transgenic mice with mice that are deficient for
Mlh1. Our findings demonstrate that Mlh1 promotes GAA repeat
expansions within intergenerational transmissions and within
selective somatic tissues. Moreover, to explore the effect of Pms2
or Mlh1 function on GAA repeat dynamics, we determined FXN
transcription levels in tissues from MMR wild type mice compared
with MMR knockout mice. Our results showed downregulation of
FXN transcription associated with loss of either Pms2 or Mlh1
proteins. We also observed a similar effect in HCT-116 human
cells, which are non-GAA repeat expansion cells that have loss of
both MLH1 and PMS2 activities. Hence, we conclude that Mlh1
and Pms2 proteins may affect FRDA through two different
mechanisms: an error prone MMR-dependent system that
promotes GAA repeat expansions and a MMR-independent
system that enhances FXN transcription.
Materials and Methods
Animal procedures
In this experiment YG22 FXNGAA transgenic mice with GAA
repeat sizes ranging 90–230 repeats were utilized [18,24]. Mice
were housed in conventional open cages with Litaspen Premium
8/20 bedding, paper wool nesting and standard fun tunnel
environmental enrichment. The animal husbandry was carried out
at 11 h dark versus 13 h light, 20–23uC temperature and 45–60%
humidity. The mice were nourished with a diet of SDS RM3
expanded food pellets and standard drinking water. All procedures
were carried out in accordance with the UK Home Office
‘Animals (Scientific Procedures) Act 1986’ and with approval from
the Brunel University Animal Welfare and Ethical Review Board.
YG22 FXNGAA transgenic mice were crossed with Pms2 or Mlh1
heterozygous knockout mice [31,32]. All mice were maintained in
a predominant C57BL/6J (B6) genetic background. Double
genetically modified mice containing the FXNGAA transgene with
the wild type, heterozygous or homozygous MMR knockout alleles
were then crossed with non-GAA transgenic mice to obtain the
necessary offspring for subsequent analyses.
Cell culture
Two human epithelial cell lines were used. NCM-460 cells,
derived from normal human intestinal mucosa epithelial, were
utilized as Mlh1 and PMS2 proficient cells [33], while HCT-116,
derived from human intestinal carcinoma, were used as MutLa
deficient cells [34]. Cells were cultured in McCoy’s medium and
incubated at 37uC, 5% CO2 and 95% humidity. Cell lines were
subcultured for 10 passages.
Trinucleotide repeat analysis
Genomic DNA was isolated from cells, tail biopsies and tissues
of MMR-deficient and MMR-proficient FXNGAA transgenic mice
by standard phenol/chloroform extraction and ethanol precipita-
tion. PCR amplification was performed to determine the GAA
repeat size of the FXN gene (NG_008845) using 200–500 ng of
DNA, a conventional PCR kit (Qiagen), GAA-F and GAA-R
primers and PCR conditions as previously described [1]. GAA
PCR products were resolved in 20 cm-long, 1.5% agarose 16
TBE gels by electrophoresis at 60–90 V for 16–20 h and GAA
band sizes were determined with comparison with 100 bp DNA
size markers (Invitrogen). GAA repeat sizes were assessed by
subtracting 451 bp of flanking non-repeat DNA from the PCR
product size and dividing the remaining base pair size by 3.
Following assessment of GAA repeat sizes, each individual GAA
repeat of the offspring was compared with the corresponding GAA
repeat of the parent, to investigate the presence/absence and
direction of any intergeneration GAA repeat instability. For
samples that demonstrated three GAA repeats, the transmission
order of the higher, middle and lower GAA repeat from parent to
offspring was considered to be maintained. A GAA repeat size in
the offspring that was larger than the parent indicated an
expansion, while one that was smaller indicated a contraction.
Additionally, parent and offspring GAA repeats of the same size
represented no change in the GAA repeat size. To determine the
mutability level, the combined number of the expanded and
contracted GAA repeats were divided by the total number of GAA
repeats analysed.
To determine presence or absence of somatic GAA repeat
instability, GAA PCR products from genomic DNA samples of
several different tissues from each mouse were run on 1.5%
agarose gels and qualitatively analysed. Stability was indicated by
the presence of discreet GAA bands, while instability was
identified as a smear of GAA PCR products, and for expansion
instability there is a generalized shift to larger GAA repeat sizes.
Mismatch repair genotype analysis
A multiplex MMR-PCR was carried out for the Pms2 gene
(NC_000071) or the Mlh1 gene (NC_000075) on each double
genetically altered mouse genomic DNA sample using 200–500 ng
DNA, Pms2-F: ACAGTTACATTCGGTGACAG and Pms2-WT:
MutLa-Protein Heterodimers Effect on FRDA
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ACTAATTCCCCTACGGTTTAG/Pms2-KO: TTTACGGAG-
CCCTGGCGC, or Mlh1-F: TGTCAATAGGCTGCCCTAGG
and Mlh1-WT: TTTTCAGTGCAGCCTATGCTC/Mlh1-KO:
TGGAAGGATTGGAGCTACGG primers and PCR conditions
were designed as 2 minutes at 95uC, followed by 35 three-step
cycles (45 sec at 95uC, 30 sec at 49uC and 45 sec at 72uC)
for Pms2-PCR, or 35 three-step cycles (45 sec at 95uC, 30 sec at
55uC and 45 sec at 72uC) for Mlh1-PCR, and ultimately
terminated with incubation at 72uC for 10 minutes. PCR products
were resolved in 1.5% agarose 16TBE gels by electrophoresis at
60–70 V for 20 minutes, compared with 1 Kb+ size marker
(Invitrogen).
Reverse transcription quantitative PCR
To determine the somatic FXN transcription level of double
genetically-modified transgenic mice, total RNA from two FRDA-
relevant tissues (brain and cerebellum) was isolated using TRIzol,
following supplier guidelines (Invitrogen). The same procedure
was applied to assess the FXN transcription level in NCM-460 and
HCT-116 human cell lines. Total RNA was treated to prevent
DNA contamination using DNase I (amplification grade, Invitro-
gen). Further to suitable RNA quality determination by A260/A280
ratio analysis by NanoDrop spectrophotometry (Invitrogen) and
agarose gel electrophoresis, total RNA samples were adjusted to
500 ng/ml with DEPC water and cDNA was subsequently
prepared by applying AMV reverse transcriptase (Invitrogen)
and oligo-dT primers. Relative reverse transcription quantitative
PCR (RT-qPCR) was performed using cDNA, power SYBR green
mastermix (Applied Biosystems) and previously described FXN
primers [23] according to the MIQE guidelines [35]. Mouse Gapdh
was used as the reference gene in mouse somatic cells and human
GAPDH was used as the reference gene in human cells, using
previously described primers [23]. RT-qPCR reactions were
performed in triplicate for each biological sample (n = 2–4) in a
real-time PCR machine (ABI prism 7900HT, Applied Biosystems)
and relative quantification values were identified by 22DDCt
method using SDS 2.4 and RQ manager software (Applied
Biosystems).
Statistical analysis
Statistical analyses were carried out using Microsoft excel 2007
software. Significant differences of the frequency distributions of
the GAA repeat size intergenerational transmission (including
three categories of ‘‘GAA repeat expansions’’, ‘‘No change’’ and
‘‘GAA repeat contractions’’) between groups of wild type,
heterozygous or homozygous MMR knockout parental genotypes
were determined by Chi squared (x2) analysis. All other
measurements, comparing two groups of sample were analyzed
using student’s t test. A P value of 0.05 was chosen as the
significance threshold.
Figure 1. Intergenerational GAA repeats. Representative example of the ethidium bromide-stained agarose gels used to determine the GAA
repeat sizes, showing GAA PCR products obtained from a YG22 GAA+/Mlh1+/+ parent and 10 GAA+ offspring. M=100 bp DNA size marker.
doi:10.1371/journal.pone.0100523.g001
Figure 2. Intergenerational GAA repeat frequencies. Analysis of
intergenerational transmission of GAA repeat expansion frequency
based on the parental genotype (WT=GAA+/Mlh1+/+, Het =GAA+/
Mlh1+/2). Frequencies of ‘GAA expansions’, ‘no change’ and ‘GAA
repeat contractions’ transmitted to offspring are represented as
percentages of total GAA repeat transmissions. Chi squared (x2)
statistical testing was applied to this expriment. WT n=30 GAA PCR
products from 10 mice; Het n = 63 GAA PCR products from 21 mice;
*** = p,0.001.
doi:10.1371/journal.pone.0100523.g002
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Results
Mlh1 activity promotes intergenerational GAA repeat
expansions
We have previously assessed the effects of Pms2 protein on
intergenerational transmission of the YG8 and YG22 FXNGAA
transgenic mice by comparing GAA repeat sizes of offspring with
those of parents containing one of three Pms2 genotypes: FXNGAA/
Pms2+/+, FXNGAA/Pms2+/2, FXNGAA/Pms22/2 [20]. Loss of
Pms2 showed an increased mutability frequency, biased towards
GAA repeat expansion in an allele-dose dependent manner. In the
current study, the effect of Mlh1 on intergenerational transmission
of the YG22 FXNGAA mouse model was similarly assessed by
comparing GAA repeat sizes of offspring with those of parents
containing different Mlh1 genotypes: FXNGAA/Mlh1+/+ (par-
ents = 2, offspring = 10) or FXNGAA/Mlh1+/2 (parents = 4, off-
spring = 21; Fig. 1). However, study of Mlh12/2 male and female
parents was not feasible, since they are sterile due to lack of the
Mlh1 protein [31]. The transmitted GAA repeat sizes were
determined (see Materials and Methods) and categorized into
‘GAA repeat expansions’, ‘no change’ or ‘GAA repeat contrac-
tions’ subsets and the percentage of frequencies, as well as mean
size changes of each subset, were determined to give an overall
‘transmission profile’. Analysis of data demonstrated a mutability
level of 86.7% in the FXNGAA/Mlh1+/+ transmission profile with a
bias towards GAA repeat expansions (Fig. 2). With loss of one
Mlh1 allele, the mutability level of the FXNGAA/Mlh1+/2
intergenerational transmission profile increased to 93.7% with a
bias towards GAA repeat contractions (Fig. 2, Table 1). This
suggests that down-regulation of Mlh1 protein leads to further
GAA repeat instability, with a switch from expansions to
contractions. Furthermore, the mean variations of GAA repeat
size (i.e. the summation of total GAA repeat changes divided by
the entire number of GAA repeat transmissions) for Mlh1+/2
shows a tendency towards contraction compared with Mlh1+/+
(Table 2). These findings suggest that Mlh1 protein can protect
against intergenerational GAA repeat contractions and may also
promote GAA repeat expansions.
Mlh1 activity also promotes somatic GAA repeat
expansions
We have previously demonstrated that loss of Pms2 leads to
increased GAA repeat expansions in FRDA-relevant tissues,
namely brain, cerebellum and DRG [27]. In this current study,
the effect of Mlh1 on the dynamics of somatic GAA repeat size was
qualitatively investigated by analyzing two neuronal tissues (brain
and cerebellum) and two non-neuronal tissues (heart and liver),
from either FXNGAA/Mlh1+/+ (Mlh1 proficient) or FXNGAA/
Mlh12/2 (Mlh1 deficient) 3–5 month-old mice. Analysis of somatic
GAA repeats from FXNGAA/Mlh1+/+ mice demonstrated expan-
sion instability in cerebellum tissue, which exhibited a smear of
GAA PCR products ranging from 210 to 236 GAA repeats,
compared with the other tissues, which contained discrete PCR
products ranging from 201 to 230 GAA repeats; Fig. 3), consistent
with our previous studies [18]. However, no such GAA repeat
instability was observed in any of the somatic tissues from
FXNGAA/Mlh12/2 mice, which comprised of discrete PCR
products ranging from 200 to 230 GAA repeats, indicating that
lack of Mlh1 protein leads to GAA repeat stabilization. This
finding suggests an essential role for Mlh1 in somatic GAA repeat
expansion instability.
Effects of Pms2 and Mlh1 on FXN transcription
Previous studies have detected an inverse correlation between
GAA repeat expansion size and FXN transcription level in FRDA
[23,36]. To determine any effect of Pms2 or Mlh1 deficiency on
FXN transcription, in addition to their effects on somatic GAA
repeat instability, we investigated brain and cerebellum tissues
from YG22 transgenic mice. In each case, two subgroups were
employed based on the MMR genotypes: FXNGAA/MMR+/+ and
FXNGAA/MMR2/2. Relative quantification of FXN transcription
in brain tissues identified a decline of approximately 30% for
FXNGAA/Pms22/2 transgenic mice compared to FXNGAA/Pms2+/
+ mice (Fig. 4A). Similarly, cerebellum tissues revealed a decrease
of FXN transcription in Pms2-deficient transgenic mice compared
with Pms2-proficient mice (Fig. 4B). These findings demonstrate
that lack of Pms2 leads to reduced levels of FXN transcription in
FRDA-relevant tissues, possibly due to the increased sizes of GAA
repeats. Further analysis of brain tissues showed that deficiency of
Mlh1 led to downregulation of FXN transcription to approxi-
mately 50% of the levels in Mlh1-proficient mice (Fig. 4A).
Moreover, study of cerebellum tissues revealed a dramatic
decrease in FXN transcription in Mlh1-deficient mice to levels of
approximately 10% compared with Mlh1-proficient mice (Fig. 4B).
These data suggest a more crucial role of Mlh1 on regulating FXN
transcription levels in brain and cerebellum tissues compared with
Pms2.
Table 1. x2 and p value analyses of intergenerational GAA repeat transmissions.
Mlh1 parental genotype 1 Mlh1 parental genotype 2 x2 value df P value
Mlh1+/+ Mlh1+/2 28.2 2 ,0.001
doi:10.1371/journal.pone.0100523.t001
Table 2. Mean intergenerational GAA repeat size variations.
Parental genotype
Mean GAA repeat size increase of
expansions
Mean GAA repeat size decrease of
contractions
Mean GAA repeat size variation of all
transmission
Mlh1+/+ +3.3 22.6 +1.86
Mlh1+/2 +2.3 23.4 22.095
doi:10.1371/journal.pone.0100523.t002
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MutLa dysfunction reduces FXN transcription in human
cells
To investigate if MutLa-heterodimer proteins also have an
effect on FXN transcription in human epithelial cell lines, we
compared NCM-460 (human MMR-proficient) cells with HCT-
116 (human MMR-deficient) cells. Observations have previously
demonstrated that HCT-116 carries a mutation within the MLH1
gene that prevents MLH1 and PMS2 protein binding, subse-
quently leading to dysfunction of MutLa-heterodimer complex
and degradation of free PMS2 [34,37,38]. Comparing these cell
lines revealed significantly higher FXN transcription in the MMR-
proficient NCM-460 control cells compared with HCT-116 cell
lines (Fig. 5). This demonstrates a consistent effect of MLH1/
PMS2 deficiency on FXN transcription in both human cells in vitro
Figure 3. Effect of Mlh1 on somatic GAA repeat dynamics. Representative image of the ethidium bromide-stained agarose gels used to
determine GAA repeat expansion dynamics from different tissues of 3–5 month-old mice in absence of presence of Mlh1. M=100 bp size marker,
B =brain, C = cerebellum, H=heart, L = liver. WT (Mlh1+/+) n = 2, KO (Mlh2/2) n = 7.
doi:10.1371/journal.pone.0100523.g003
Figure 4. Effect of MutLa components on somatic FXN transcription in vivo. Relative RT-qPCR analyses of somatic FXN transcription level
based on the MMR genotype (WT, Pms2 KO or Mlh1 KO) in (A) FXNGAA/MMR brain tissues (n = 2–4), and (B) FXNGAA/MMR cerebellum tissues (n = 2–4).
Statistical analysis of the experiment was perform using the student’s t test. Error bars = S.E.M, * = p,0.05, ** = p,0.01, *** = p,0.001.
doi:10.1371/journal.pone.0100523.g004
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Figure 5. Effect of the MutLa-complex on FXN transcription in vitro. Relative RT-qPCR analyses of the mean FXN transcriptional level, isolated
from MMR-proficient human cells, NCM-460, and MutLa heterodimer-deficient cells, HCT-116 (n = 3). Statistical analysis of the experiment was
perform using the student’s t test. Error bars = S.E.M, * = p,0.05, ** = p,0.01, *** = p,0.001.
doi:10.1371/journal.pone.0100523.g005
Figure 6. Proposed mechanism of MMR action on intergene-
tional GAA repeat expansions. Schematic images representing: (A)
a small loop caused by triplex DNA structure; (B) recognition of the loop
by the MutS complex, cleavage with endonuclease (ENDO), opening of
the loop, recruitment of MutLa and synthesis of expanded DNA, and (C)
end of repair by ligation of the further expanded strand and release of
MMR proteins.
doi:10.1371/journal.pone.0100523.g006
Figure 7. Proposed mechanism of MMR action on post-mitotic
somatic GAA repeat expansions. Images represent: (A) a small GAA
loop is formed as part of the triplex DNANRNA R-loop structure caused
by transcription within GAA repeats; (B) recognition of the small GAA
loop by MutS-heterodimers, cleavage of the CTT DNA strand with an
endonuclease (ENDO) and recruitment of MutLa, and (C) release of the
RNA, synthesis of expanded DNA and end of repair by ligation of the
expanded strand and release of MMR proteins.
doi:10.1371/journal.pone.0100523.g007
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and FXNGAA mouse tissues in vivo. Overall, these findings suggest
an essential role for MutLa-heterodimer proteins in the regulation
of FXN transcription.
Discussion
MutLa proteins play distinct roles in both
intergenerational and somatic GAA repeat instability in
FRDA
We have previously demonstrated an important role for Pms2
protein in promoting GAA repeat contractions and protecting
GAA repeats against further expansions in transmission from
parents to offspring [20]. It has also been demonstrated that Pms2
inhibits somatic GAA repeat expansions in neuronal tissues [27].
To further investigate the role of the MMR system in FRDA, we
analyzed the effect of Mlh1 protein on intergenerational and
somatic GAA repeat expansion instability in YG22 FXNGAA
transgenic mice. With loss of Mlh1, intergenerational GAA repeat
mutability increases, agreeing with the accepted role of Mlh1
within the MutLa-heterodimer complex of the MMR system, to
interact with one of MutSa (Msh2-Msh6) or MutSb (Msh2-Msh3)
heterodimers and continue the DNA repair process during
replication and recombination [29,39]. However, further analysis
of Mlh1 dysfunction showed that the increased mutability of the
expanded GAA repeats was biased towards contractions and
hence activity of this protein actively promotes GAA repeat
expansions. This is not compatible with the canonical DNA repair
function of Mlh1 within the MMR system. It is not yet clear how
Mlh1 activity is able to promote intergenerational transmission of
GAA repeat expansions. One possibility is that the MMR system
promotes expansions in GAA repeat regions through an unknown
error-prone mechanism.
It is generally accepted that repeat expansions can form
different types of non-B DNA structures during DNA replication.
Meanwhile, it has been demonstrated that GAA repeat expansions
can also form triplexes between intramolecular GAANGAANTCC
(RNR NY) sequences [40], or even more complicated form of sticky
DNA by binding two separate GAA repeats in naked supercoiled
DNA [41,42]. Similar sequences might lead to incompetent DNA
replication. Evidence indicates that the MMR system may be
recruited to correct such non-canonical DNA structures [43],
although the mechanism might be different for intergenerational
GAA repeat instability compared with somatic GAA repeat
instability. Briefly, in the case of intergenerational GAA repeat
expansion, a small loop which is produced as a consequence of
GAA triplex formation could initially be recognized by MutSa or
MutSb complex (Fig. 6A). Interestingly, it has previously been
demonstrated that occupancy of MutSb protein components,
Msh2 and Msh3, and to a lesser extent Msh6, is increased in the
downstream region of expanded GAA repeat sequences, presum-
ably due to binding to the expanded GAA repeats [20,44]. These
data suggest a higher likelihood of the MutSb complex to bind to
the GAA repeat region, although further studies are required to
confirm this. In any event, one of the MutS complexes may initiate
the MMR mechanism by recognizing and binding to a DNA
triplex loop of expanded GAA repeat sequences [43,45]. Following
MutS complex binding to the triplex DNA loop, a MMR-directed
excision might be developed by endonuclease activity [45] within
the single-strand of DNA facing opposite to the loop. This event
may subsequently lead to recruitment of the MutLa complex and
other coordinating factors to proceed with the MMR system
(Fig. 6B) [45]. Concurrently, an alternative enzyme (presumably a
helicase [46]) may open up the triplex sequence, creating a gap in
the nicked opposing strand of DNA, which is filled with additional
sequence by a DNA polymerase (Fig. 6C) [28,47]. Thus, this event
may not only resolve the GAA repeat triplex structure [45], but
may at the same time cause further GAA repeat expansions.
However, this proposed mechanism does not account for how loss
of Pms2 can cause the observed increased magnitude of GAA
repeat expansions. Hence, we would suggest that Pms2 can
promote GAA repeat contractions by another mechanism.
Moreover, this mechanism is only able to explain the potential
correlations of GAA repeat expansions, DNA triplex structure
formation and MMR-error prone activity in the cells with DNA
replication ability (e.g. mitotic cells, such as germ cells or stem
cells), hence it is not able to demonstrate the mechanism whereby
MMR activity promotes GAA repeat expansions in non-dividing
adult somatic cells (i.e. post mitotic cells, such as mature neuronal
cells).
The results of our somatic GAA repeat expansion studies
showed that loss of Mlh1 protein leads to stabilization of the
expanded GAA repeats in somatic tissues, either due to protection
against further GAA repeat expansions or promotion of GAA
repeat contractions in neuronal tissues. Despite detecting similar
effects of Mlh1 on the dynamics of GAA repeat expansions, we
would propose that the Mlh1 mechanism of action may be
different between intergenerational transmission and somatic cells.
Previous studies have suggested that binding of premature GAA
repeat mRNA with the relevant DNA sequence can produce an
unusual DNANRNA triplex (R-loop) structure in vitro and in
bacteria [4,48], which culminates in stalling of RNA polymerase II
[49,50]. Therefore, in the case of post mitotic GAA repeat
expansions, a non-canonical R-loop structure might be created
during binding of single-stranded template TTC repeat sequences
Figure 8. Proposed mechanism of MLH1 action on FXN
transcription. Images illustrate: (A) inhibition of transcription by
triplex DNANRNA R-loop formation; (B) binding of MLH1 and MSH6 to
the R-loop, together with other unknown factors (?), and (C) release of
bound premature mRNA to allow continuation of transcription.
doi:10.1371/journal.pone.0100523.g008
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to transcribed GAA mRNA, forming small loop-outs of the single
stranded non-template GAA repeats (Fig. 7A) [4,48]. Evidence
shows that these small loop-outs may then be recognized by one of
the MutS complexes, subsequently binding with the MutLa
complex (Fig. 7B) [51,52]. As part of the repair mechanism, a
MMR-directed excision may be made in the TTC template strand
of DNA (Fig. 7B) [28] and the stalled mRNA may be released
from the template strand by helicase enzyme activity. Subse-
quently, the MutS and MutLa complexes may recruit other MMR
system factors (i.e. PCNA, RFC and DNA polymerase [45]) to
repair the cut TTC strand of DNA, but with the introduction of
expanded repeat sequences (Fig. 7C). Since GAA repeat expan-
sions occur predominantly in tissues that contain mainly non-
dividing cells (e.g. brain and cerebellum), a transcriptional-based
mechanism may indeed be the most pertinent model to explain the
role of the MMR system in somatic GAA repeat expansions.
MutLa proteins contribute to the regulation of FXN
transcription
In this study, we also identified an effect of MutLa-heterodimer
proteins on FXN transcription. Thus, disruption of either Mlh1 or
Pms2 was shown to downregulate FXN transcription in vivo and in
vitro. Curiously, this mode of action is associated both with and
without somatic GAA repeat instability (Table 3). Thus, loss of
Pms2 causes further increased somatic GAA repeat expansions
and a corresponding down-regulation of FXN transcription. In
contrast, Mlh1 disruption also results in down-regulation of FXN
transcription, in spite of a corresponding loss of somatic GAA
repeat expansion (Table 3). Although the reasons for these
conflicting results are not yet clear, it is proposed that another
mechanism, distinct from the MMR system, which is not involved
in GAA repeat expansions, might lead to down-regulation of FXN
transcription with Mlh1 deficiency. Interestingly, in addition to its
contribution to the MMR system, the MLH1 protein is also able to
cooperate with the transcriptional-coupled nucleotide excision
repair (TC-NER) system to amend genomic errors with bulky
helix loops [53,54]. The TC-NER system is generally recruited to
repair genomic errors, led by preferentially binding transcription
sequences and RNA polymerase II to the transcribed DNA strand
in the expressed genes [54,55]. Investigations of HCT-116 MLH1-
deficient cells have revealed hypersensitivity to UV light due to
dysfunction of TC-NER, while artificially introduction of MLH1
gene to this cell line leads to TC-NER system activity and hence
reduced sensitivity to UV light [54,56]. It has also been reported
that dysfunction of TC-NER system down-regulates transcription
of particular genes [57]. These observations suggest that there may
be a similar MLH1 mechanism of action on the regulation of FXN
transcription. In our proposed model, a complex of unwound
DNA, primary FXN mRNA sequence and RNA polymerase II
may combine to form an unusual R-loop structure (Fig. 8A),
leading to further somatic GAA repeat expansions on the one
hand and FXN transcription blockage on the other. MLH1 may
act in a complex with other proteins (e.g. MSH6) in the TC-NER
system to repair the R-loop errors and consequently increase FXN
transcription (Fig. 8B). Activation of this protein complex might
assist in the release of stalled RNA polymerase II, culminating in
resumption of FXN transcription (Fig. 8C). In contrast, without
MLH1, the TC-NER protein complex would be incomplete and
non-functional. Therefore, RNA polymerase II would remain
stalled due to failure of the TC-NER system (Fig. 8A) and blockage
of FXN transcription would persist.
Conclusions
Our findings highlight the importance of the MutLa compo-
nents, PMS2 and MLH1, in both the dynamics of GAA repeat
expansion and FXN transcription. We conclude that, in addition to
previously proposed therapeutic option to inhibit MSH3 action
[20], identifying compounds which upregulate PMS2 activity
could perhaps be considered as a therapeutic approach to prevent
progressive GAA repeat expansion instability and elevate FXN
expression. However, great caution should be taken since previous
studies have reported hypermutability, DNA damage tolerance
and tumorigenesis as consequence of PMS2 overexpression [58].
In addition, compounds that upregulate MLH1 activity and hence
cause increased FXN expression could also be considered as a
potential FRDA therapy. However, in this case GAA repeat
expansions might simultaneously be promoted in FRDA cells with
an independent mechanism of action to FXN transcription. Thus,
further investigations will be required to clarify the precise
mechanisms of action of MLH1 in GAA repeat instability and
FXN transcription before being fully considered as a target for
FRDA therapy.
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